A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines
Clinical trial NCT00110305 · COMPLETED
Trial details
- NCT number
- NCT00110305
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2011-12-01
- Enrollment
- 368
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.